Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) EBITDA (2016 - 2025)

CNL Healthcare Properties (CHTH) has 14 years of EBITDA data on record, last reported at $22.3 million in Q3 2025.

  • For Q3 2025, EBITDA rose 7.65% year-over-year to $22.3 million; the TTM value through Sep 2025 reached $85.5 million, up 11.9%, while the annual FY2024 figure was $81.5 million, 27.85% up from the prior year.
  • EBITDA reached $22.3 million in Q3 2025 per CHTH's latest filing, down from $22.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $22.8 million in Q2 2025 and bottomed at $3.6 million in Q4 2021.
  • Average EBITDA over 5 years is $16.9 million, with a median of $16.7 million recorded in 2023.
  • Peak YoY movement for EBITDA: tumbled 71.56% in 2021, then skyrocketed 268.24% in 2022.
  • A 5-year view of EBITDA shows it stood at $3.6 million in 2021, then surged by 268.24% to $13.3 million in 2022, then increased by 7.0% to $14.2 million in 2023, then surged by 35.62% to $19.3 million in 2024, then rose by 15.71% to $22.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $22.3 million in Q3 2025, $22.8 million in Q2 2025, and $21.2 million in Q1 2025.